Ann M Neumeyer1, Natalia Cano Sokoloff2, Erin McDonnell3, Eric A Macklin4, Christopher J McDougle5, Madhusmita Misra6. 1. Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA; Harvard Medical School, Boston, MA. Electronic address: aneumeyer@mgh.harvard.edu. 2. Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA. 3. Biostatistics Center, Massachusetts General Hospital, Boston, MA. 4. Harvard Medical School, Boston, MA; Biostatistics Center, Massachusetts General Hospital, Boston, MA. 5. Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA; Harvard Medical School, Boston, MA. 6. Harvard Medical School, Boston, MA; Pediatric Endocrine and Neuroendocrine Units, Massachusetts General Hospital, Boston, MA.
Abstract
OBJECTIVE: To test the hypothesis that bone accrual over a 4-year period is reduced in boys with autism spectrum disorder (ASD) compared with typically developing controls. STUDY DESIGN: Twenty-five boys with ASD and 24 controls were assessed for bone outcomes. Fourteen boys with ASD and 11 controls were assessed both at baseline and after 4 years. The mean subject age was 11.0 ± 1.6 years at study initiation and 14.9 ± 1.6 years at follow-up. Bone mineral density (BMD) was measured at the spine, hip, and whole body using dual-energy X-ray absorptiometry and normalized for age, race, and sex (BMD z-scores). Height adjustments were performed as well. We assessed medical history, physical activity using questionnaires, vitamin D and calcium intake using food records, and serum calcium, phosphorus, 25(OH)-vitamin D, and pubertal hormone levels. RESULTS: Boys with ASD had lower spine, hip, and whole body BMD z-scores compared with controls. In those subjects assessed both at baseline and after 4 years, bone accrual rates did not differ between the 2 groups; however, spine and hip BMD z-scores remained lower in the boys with ASD than in controls at follow-up. Notably, the ASD group was less physically active at both time points. CONCLUSION: Although pubertal bone accrual was similar to that in controls, BMD in children with ASD remained low over a 4-year follow-up period, suggesting that low BMD is a consequence of prepubertal factors, such as low physical activity. Studies are needed to investigate the causes and consequences of decreased BMD, to assess BMD in females and adults with ASD, and to evaluate therapeutic interventions.
OBJECTIVE: To test the hypothesis that bone accrual over a 4-year period is reduced in boys with autism spectrum disorder (ASD) compared with typically developing controls. STUDY DESIGN: Twenty-five boys with ASD and 24 controls were assessed for bone outcomes. Fourteen boys with ASD and 11 controls were assessed both at baseline and after 4 years. The mean subject age was 11.0 ± 1.6 years at study initiation and 14.9 ± 1.6 years at follow-up. Bone mineral density (BMD) was measured at the spine, hip, and whole body using dual-energy X-ray absorptiometry and normalized for age, race, and sex (BMD z-scores). Height adjustments were performed as well. We assessed medical history, physical activity using questionnaires, vitamin D and calcium intake using food records, and serum calcium, phosphorus, 25(OH)-vitamin D, and pubertal hormone levels. RESULTS:Boys with ASD had lower spine, hip, and whole body BMD z-scores compared with controls. In those subjects assessed both at baseline and after 4 years, bone accrual rates did not differ between the 2 groups; however, spine and hip BMD z-scores remained lower in the boys with ASD than in controls at follow-up. Notably, the ASD group was less physically active at both time points. CONCLUSION: Although pubertal bone accrual was similar to that in controls, BMD in children with ASD remained low over a 4-year follow-up period, suggesting that low BMD is a consequence of prepubertal factors, such as low physical activity. Studies are needed to investigate the causes and consequences of decreased BMD, to assess BMD in females and adults with ASD, and to evaluate therapeutic interventions.
Authors: C M Smith; N P Wright; J K H Wales; C Mackenzie; R A Primhak; R Eastell; J S Walsh Journal: Clin Endocrinol (Oxf) Date: 2011-10 Impact factor: 3.478
Authors: Yvette Roke; Peter N van Harten; Jan K Buitelaar; Diederik E Tenback; Lorentz G B A Quekel; Yolanda B de Rijke; Annemieke M Boot Journal: Eur J Endocrinol Date: 2012-09-25 Impact factor: 6.664
Authors: Mary L Hediger; Lucinda J England; Cynthia A Molloy; Kai F Yu; Patricia Manning-Courtney; James L Mills Journal: J Autism Dev Disord Date: 2008-05
Authors: Vina P S Tan; Heather M Macdonald; SoJung Kim; Lindsay Nettlefold; Leigh Gabel; Maureen C Ashe; Heather A McKay Journal: J Bone Miner Res Date: 2014-10 Impact factor: 6.741
Authors: Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle Journal: Psychopharmacology (Berl) Date: 2019-05-28 Impact factor: 4.530
Authors: Ann M Neumeyer; Natalia Cano Sokoloff; Erin I McDonnell; Eric A Macklin; Christopher J McDougle; Tara M Holmes; Jane L Hubbard; Madhusmita Misra Journal: J Acad Nutr Diet Date: 2018-03-02 Impact factor: 4.910
Authors: Kelly Barnhill; Lucas Ramirez; Alan Gutierrez; Wendy Richardson; C Nathan Marti; Amy Potts; Rebeca Shearer; Claire Schutte; Laura Hewitson Journal: J Autism Dev Disord Date: 2017-11
Authors: Daniel G Whitney; Michelle S Caird; Karl J Jepsen; Neil S Kamdar; Christina N Marsack-Topolewski; Edward A Hurvitz; Mark D Peterson Journal: Bone Date: 2019-10-24 Impact factor: 4.398
Authors: Meena Balasubramanian; Rebecca Jones; Elizabeth Milne; Charlotte Marshall; Paul Arundel; Kath Smith; Nicholas J Bishop Journal: Bone Rep Date: 2018-04-18